Great Hill Partners, a private equity firm that invests in high-growth, disruptive companies, led a $100m Series F round in IVX Health, a national provider of outpatient infusion centers. "IVX Health is disrupting a distinct and rapidly growing healthcare vertical – biologic infusion and injection therapy – in unique ways that are driving tangible efficiencies for the US healthcare system as a whole. We are excited to play a strategic, supporting role in fueling IVX Health’s next phase of growth as it enters new markets and collaborates with other providers in the healthcare ecosystem to drive value while continuing to redefine the care experience for its patients and referring providers," Mark Taber, Great Hill Partners Managing Director.